
Anna Martling
Anna Martling is research group leader of the group Colorectal Surgery at the Department of Molecular Medicine and Surgery.
Colorectal cancer is the third most common cancer worldwide with about 1 million new cases per year. Within the group Colorectal Surgery, we perform both clinical and experimental research in the areas of 1) primary operable rectal cancer 2) locally advanced rectal cancer, and 3) primary colon cancer and metastatic colorectal cancer.
Anna Martling is research group leader of the group Colorectal Surgery at the Department of Molecular Medicine and Surgery.
Caroline Nordenvall is research group leader of the group Colorectal Surgery at the Department of Molecular Medicine and Surgery.
Please visit the Swedish site for an overall view of our research.
ALASCCA is a prospective, randomized, double blinded, placebo controlled, multicenter, biomarker-based study of adjuvant treatment with ASA in colorectal cancer.
The Stockholm III trial is a randomised, multicentre trial, comparing different radiationtherapy courses in primary resectable rectal cancer.
Address: Elite Hotell, plan 2, Eugeniavägen 6, 171 64 Solna